<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92317">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01785654</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-0142</org_study_id>
    <secondary_id>DC-2012-1501</secondary_id>
    <nct_id>NCT01785654</nct_id>
  </id_info>
  <brief_title>Hemodynamic and Biological Evaluations During Reventilation Collapse in ICU</brief_title>
  <acronym>REVECOL</acronym>
  <official_title>Hemodynamic and Biological Evaluations During Reventilation Collapse in ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, observational clinical multicentric study in ICU; during the period surrounding
      the orotracheal intubation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Main objective: to describe the characteristics of reventilation collapse: collapse rate,
      duration and treatment implemented

      Secondary objectives:

        -  identify risk factors of reventilation collapse

        -  compare mortality, hemodynamic, respiratory, infectious and biological data between
           collapse group and no reventilation collapse group.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>N/A</study_design>
  <primary_outcome>
    <measure>Reventilation collapse</measure>
    <time_frame>at day 1 (at least thirty minutes despite 500 or 1000ml of fluid resuscitation)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>reventilation collapse</measure>
    <time_frame>in the last 72 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>at day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality</measure>
    <time_frame>at day 28</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Arterial Line</condition>
  <condition>Consent of Patients</condition>
  <condition>Adult Patients</condition>
  <condition>Tracheal Intubation in ICU</condition>
  <arm_group>
    <arm_group_label>reventilation collapse</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Defined population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Arterial line

          -  Consent of patients

          -  Adult patients

          -  Tracheal intubation in ICU

        Exclusion Criteria:

          -  tracheal intubation for cardiac arrest

          -  pregnant woman

          -  major protected
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sebastien PERBET</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick LACARIN</last_name>
    <phone>04 73 75 11 95</phone>
    <email>placarin@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patrick LACARIN</last_name>
      <phone>04 73 75 11 95</phone>
      <email>placarin@chu-clermontferrand.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 5, 2013</lastchanged_date>
  <firstreceived_date>February 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Reventilation collapse</keyword>
  <keyword>Rate of reventilation collapse</keyword>
  <keyword>Risk factor of reventilation collapse</keyword>
  <keyword>Hemodynamic profile of reventilation collapse</keyword>
  <keyword>Biologic approach of reventilation collapse</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
